•                                                                                         
    • Overview
    • The History
    • Leadership Team
      • William C. Weldon
      • Robert A. Ingram
      • Christopher A. Viehbacher
      • H. Edward Hanway
      • Martin J. Murphy
      • Gregory A. Curt
      • Mace Rothenberg
      • Judy O'Hagan
      • John N. Dornan
    • Task Forces at a Glance
    • Vendor Endorsement Policy
    • FAQs
       
  •                                             
    • News
    • Press Releases
    • Videos
       



Leadership Team

Executive Committee of the CEO Roundtable on Cancer

Weldon_Bill.JPG   William C. Weldon
Chairman, CEO Roundtable on Cancer
Chairman of the Board and Chief Executive Officer, Johnson & Johnson

Robert_Ingram.JPG   Robert A. Ingram
Past Chairman and Co-Founder, CEO Roundtable on Cancer
General Partner, Hatteras Venture Partners

Chris.JPG   Christopher A. Viehbacher
Vice Chairman, CEO Roundtable on Cancer
Chief Executive Officer, sanofi-aventis

HEH.JPG   H. Edward Hanway
Treasurer, CEO Roundtable on Cancer
Chairman Emeritus, CIGNA

MurphyM.JPG   Martin J. Murphy, Jr., Ph.D., DMedSc
Chief Executive Officer, CEO Roundtable on Cancer
Chairman of the Board and Chief Executive Officer, AlphaMed Consulting

Life Sciences Consortium Task Force Leadership

Greg-Curt.jpg   Gregory A. Curt, M.D.
Chairman, Life Sciences Consortium Task Force
US Medical Science Lead for Emerging Products, AstraZeneca Oncology

MaceRothenberg.JPG   Mace L. Rothenberg, M.D.
Vice Chairman, Life Sciences Consortium Task Force
Senior Vice President of Clinical Development and Medical Affairs for the Oncology Business Unit at Pfizer’s Global Research and Development

CEO Cancer Gold StandardTM Task Force Leadership

  Judy O’Hagan
Chairman, CEO Cancer Gold StandardTM Task Force
Vice President, US, Human Resources sanofi-aventis

CEO Roundtable on Cancer Staff

Dornan_John.JPG   John N. Dornan, Jr.
Executive Director, CEO Roundtable on Cancer



 

 

July 29 2010
Blue Cross Blue Shield of North Carolina awarded CEO Cancer Gold StandardTM accreditation

CARY, NC (July 29, 2010) – Blue Cross and Blue Shield of North Carolina (BCBSNC) has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Read More

June 21 2010
Publicis awarded CEO Cancer Gold StandardTM accreditation

CARY, NC (June 21, 2010) – Publicis Healthcare Communications Group (PHCG), the world's largest healthcare communications group, has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Read More

January 21 2010
The CEO Roundtable on Cancer Salutes SAS and Meridian Health

The CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, salutes SAS Institute for being ranked No.1 on FORTUNE magazine’s annual “100 Best Companies to Work For” list.
Read More

Contact Us
Privacy Policy
Terms Of Use
Technical Support
Site Map
Copyright 2010
Print Page Email Page to Friend Feedback